MedTrace Logo

Transcranial Magnetic Stimulation (TMS) for Thoracic Surgery

NCT03994991 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-05-24

No results posted yet for this study

Summary

Patients with high severity of post-surgical pain scores will be randomized to transcranial magnetic stimulation (TMS) vs sham TMS groups. Both group of patients will have 10 TMS sessions during 5 days. Our hypothesis is that, the reduction in the severity of pain scores will be greater among those patients who are randomized to active TMS group compared to sham TMS group. The investigators will explore how improvements in pain correlate with changes in brain network connectivity.

Conditions

  • Thoracic Surgery
  • Chronic Pain
  • Transcranial Magnetic Stimulation
  • Neuromodulation

Interventions

DEVICE

active TMS

Transcranial magnetic stimulation

DEVICE

sham TMS

Sham transcranial magnetic stimulation

Sponsors & Collaborators

  • Emine Bayman

    lead OTHER

Principal Investigators

  • Emine O Bayman · University of Iowa

  • Jatin Vaidya, PhD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-05-19
Completion
2021-05-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994991 on ClinicalTrials.gov